GSK plc
GSKNYSE
Product information
What is GSK plc (GSK)?
GSK plc is a UK-based biopharma company. Its ordinary shares trade on the London Stock Exchange; the security trading on the New York Stock Exchange under the ticker GSK belongs to the company's American depositary receipt (ADR/ADS) program.
The company's operations are grouped under vaccines, specialty medicines and general medicines. The vaccine portfolio includes products against diseases such as shingles, meningitis and respiratory syncytial virus (RSV). Specialty medicines include HIV treatments, run through ViiV Healthcare, in which it is the majority shareholder, as well as drugs in respiratory, immunology and oncology. General medicines consist of established products such as asthma and COPD inhalers and antibiotics. The consumer health business was separated as Haleon and is no longer part of GSK.
For pharmaceutical companies, patent terms, clinical trial results, US drug pricing policies, vaccine demand and legal proceedings are watched. The GSK page on Lzzo.com presents the ADR price in US dollars; users can see the Turkish lira, euro or pound sterling equivalent. A price history chart, technical indicators, the data source and the time of the last update are also on the page.
Sources: gsk.com
- Name
- GSK plc
- Symbol
- GSK
- Market
- Stocks
What to look for in the technical analysis of GSK plc
Moving averages help assess the trend and RSI helps assess momentum. Indicators are calculated from real history; when there is not enough history or the required candle fields are missing, the indicator is not calculated. Past results do not guarantee future performance.
Technical indicators
Calculated from observed daily candles (at least 201 observations). No intraday indicators. Indicators are descriptive, not a buy/sell recommendation.
Investment Return CalculatorWith observed closes over the past year
Loading historical prices…